X Yin, H Liao, H Yun, N Lin, S Li, Y Xiang… - Seminars in cancer biology, 2022 - Elsevier
Lung cancer accounts for the main proportion of malignancy-related deaths and most patients are diagnosed at an advanced stage. Immunotherapy and targeted therapy have …
Radiotherapy (RT) is still one of the standard cancer therapies, with up to two third of all cancer patients with solid tumors being irradiated in the course of their disease. The aim of …
Z Xu, Y Huang, C Hu, L Du, YA Du, Y Zhang, J Qin… - Gut, 2023 - gut.bmj.com
Objective Metabolic biomarkers are expected to decode the phenotype of gastric cancer (GC) and lead to high-performance blood tests towards GC diagnosis and prognosis. We …
Y Yang, Y Zhao, X Liu, J Huang - Seminars in Cancer Biology, 2022 - Elsevier
Artificial intelligence (AI) indicates the application of machines to imitate intelligent behaviors for solving complex tasks with minimal human intervention, including machine learning and …
R Song, F Liu, Y Ping, Y Zhang, L Wang - Biomarker Research, 2023 - Springer
Immune checkpoint inhibitors (ICIs) have dramatically enhanced the treatment outcomes for diverse malignancies. Yet, only 15–60% of patients respond significantly. Therefore …
M Hecht, M Eckstein, S Rutzner… - … for ImmunoTherapy of …, 2022 - ncbi.nlm.nih.gov
Purpose The first aim of the trial is to study feasibility of combined programmed death protein ligand 1/cytotoxic T-lymphocyte-associated protein 4 inhibition concomitant to radiotherapy …
Strong rationale and a growing number of preclinical and clinical studies support combining radiotherapy and immunotherapy to improve patient outcomes. However, several critical …
Y Chen, S Wen, J Xia, X Du, Y Wu, B Pan… - Frontiers in …, 2021 - frontiersin.org
Background PD-1 inhibitors have been routinely used in the treatment of advanced non- small cell lung cancer (NSCLC), and have demonstrated to significantly improve …
M Guida, N Bartolomeo, D Quaresmini… - Journal of translational …, 2022 - Springer
Background To evaluate the capability of basal and one-month differed white blood cells (WBC), neutrophil, lymphocyte and platelet values and their ratios (neutrophils-to …